WebAug 28, 2024 · Among patients at high risk for bleeding who had undergone implantation with a biodegradable-polymer sirolimus-eluting stent for an acute or chronic … 這個月看急診照會，最常被問的問題之一就是”請問有沒有要用DAPT(dual-antiplatelet therapy)?”(同時也是我對照會常問主治醫師的問題XD)。 剛好上週去聽完腦中風年會，決定來整理台灣腦中風學會的治療指引。 See more 終於要進入正題了! DAPT研究最多的組合是Aspirin + Clopidogrel，後面討論的大部分都是這個組合。 其他組合 1. Aspirin + Cilostazol: 研究不多，好像比單用Aspirin更有效，目前還沒有跟Aspirin + Clopidogrel的正面比 … See more

Dual Antiplatelet Therapy IntechOpen

WebDual antiplatelet therapy has become the cornerstone of the treatment of acute coronary syndromes with or without stent implantation. 1 Although there is consensus about the indication for dual antiplatelet therapy, there is little evidence about the optimal duration of therapy. In patients surviving non-ST-segment-elevation acute coronary syndromes one … WebSep 16, 2009 · The DAPT Study is a double blind randomized controlled trial intended to determine the appropriate duration for dual antiplatelet therapy (the combination of aspirin and a second anti-clotting medication) as well as the safety and effectiveness of dual antiplatelet therapy to protect patients from stent thrombosis and major adverse … jpwebカード

dual antiplatelet therapy - UpToDate

WebJan 14, 2024 · Yet, dual antiplatelet therapy seems to reduce the long-term risk of non-stent-related infarction and stroke. 12, 13 Hence, after 21 years of research, dual antiplatelet therapy has moved from a local, i.e. stent-related, to a systemic treatment strategy, i.e. capable of preventing thrombotic arterial occlusions, conveying global … WebNov 16, 2014 · The use of dual antiplatelet therapy in which a P2Y12-receptor inhibitor is combined with aspirin is critically important for the prevention of coronary stent … WebTargeting endothelial cell metabolism: new therapeutic prospects?主要由Annalisa Zecchin、Aleksandra Brajic、Peter Carmeliet编写，在2015年被《中国高等学校学术文摘·生物学》收录，原文总共16页。 adicionar site como confiável edge